Conversely, Fitch et al. [29] reported that decreased IL-10 levels accelerated B-cell neoplasms, highlighting the complex role of IL-10 in leukemogenesis and the dysregulated redox landscape in pediatric ALL neoplasms that primes them for leukemic transformation. The gene discussed is IL10; the disease is B-cell neoplasm.